EFFICACY OF UPADACITINIB INDUCTION THERAPY IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS BY BIOLOGIC INADEQUATE RESPONDER STATUS: RESULTS FROM TWO RANDOMIZED PHASE 3 STUDIES

Severine Vermeire  ¹     Satoshi Tanida  ²     Hu Renwei  ³     Remo Panaccione  ⁴     Xavier Hebuterne  ⁵     David T. Rubin  ⁶     Ilo Dapo  ⁷     Zhou Wen  ⁷     Michael Weinreich  ⁷     Zhou Qing  ⁷     Silvio Danese  ^8    
1 University Hospital Leuven, Leuven, Belgium
² Nagoya City University, Nagoya, Japan
³ West China Hospital, Sichuan University, Chengdu, China
⁴ University of Calgary, Calgary, Canada
⁵ Department of Gastroenterology and Clinical Nutrition, Nice, France
⁶ The University of Chicago Medicine Inflammatory Bowel Disease Center, Chicago, United States
⁷ AbbVie, North Chicago, United States
⁸ Humanitas University and Humanitas Research Hospital, Milan, Italy

Topic
IBD, Immunology, Paediatrics

Session
IBD: Clinical trials I

Conference
UEG Week Virtual 2021

Citation
United European Gastroenterology Journal 2021; 9 (Supplement 8)